Sensus Healthcare (SRTS) Long-Term Investments (2016)

Sensus Healthcare's (SRTS) quarterly Long-Term Investments came in at $1.1 million in Q4 2016.

Sensus Healthcare (SRTS) Long-Term Investments (2016) Analysis & Trends

Sensus Healthcare's Long-Term Investments history runs 1 years deep, the most recent figure standing at $1.1 million for Q4 2016.

  • On a quarterly basis, Long-Term Investments changed N/A year-over-year to $1.1 million in Q4 2016; TTM through Dec 2016 was $1.1 million, a N/A change from a year earlier, with the FY2016 full-year figure at $1.1 million, changed N/A from the prior year.
  • Long-Term Investments steadied at $1.1 million in Q4 2016 per SRTS's latest filing.
  • Across five years, Long-Term Investments topped out at $1.1 million in Q4 2016 and bottomed at $1.1 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.09 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 285.60 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 166.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 121.00 Mn
10 Sensus Healthcare 50.14 Mn 31.81 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 1.10 Mn